bioRxiv Science⌕ Search

Biology subjects

Guryleva, M. V.

Publications and source records attributed to Guryleva, M. V..

3 recordsLinked to original sources

Inferring differentiation trajectories from T cell clonotype distributions

Single-cell RNA sequencing (scRNA-seq) enables reconstruction of cellular differentiation trajectories, but most trajectory inference methods rely largely on gene expression and overlook lineage relationships. In T lymphocytes, the T cell receptor (TCR) provides a unique, endogenous barcode that is stably inherited during clonal expansion. Here we introduce PhyloTrajectory, a framework that leverages TCR-based clonotype frequencies together with scRNA-seq to infer T cell differentiation dynamics. By modeling clonotype frequency evolution as a continuous stochastic process, PhyloTrajectory reconstructs differentiation tree topologies from clonotype frequencies across cellular subsets. We investigate the ability to recover the underlying tree topology using simulated data, and apply our approach to CD4+ T cells in murine models of allergic inflammation and viral infection. We further demonstrate that PhyloTrajectory is useful in the context of exogenously introduced barcodes. Overall, this shows that a stochastic model of clonal expansion can be used to infer cell state transitions from clonotype frequencies.

bioinformatics↗

Antigen affinity and site of immunization dictate B cell recall responses

Protective antibodies against HIV-1 require unusually high levels of somatic hypermutations (SHMs) introduced in germinal centers (GCs). To achieve this, a sequential vaccination approach was proposed. Using HIV-1 antibody knock-in mice with fate-mapping genes, we examined if antigen affinity affects the outcome of the B cell recall response. Compared to high affinity boost, low affinity boost resulted in decreased numbers of memory-derived B cells in secondary GCs, but with higher average SHM, indicating an affinity threshold for memory B cells to enter secondary GCs. Upon boosting local LNs, numbers of residual GC B cells increased independent on antigen affinity, while average SHM decreased. Our results demonstrate that antigen affinity and location of the boost affect the outcome of the B cell recall response. These results can help guide the design of vaccine immunogens aiming to selectively engage specific B cell clones for further SHM diversification.

immunology↗

Vaccine Elicitation of HIV Broadly Neutralizing Antibodies from Engineered B cells

HIV broadly neutralizing antibodies (bnAbs) can suppress viremia and protect against infection1. However, their elicitation is made difficult by low frequencies of appropriate precursor B cell receptors and the complex maturation pathways required to generate bnAbs from these precursors2. Antibody genes can be engineered into B cells for expression as both a functional receptor on cell surfaces and as secreted antibody3-5. Here, we show that HIV bnAb-engineered primary mouse B cells can be adoptively transferred and vaccinated in immunocompetent wild-type animals resulting in the expansion of durable bnAb memory and long-lived plasma cells. Somatic hypermutation after immunization indicated that engineered cells have the capacity to respond to an evolving pathogen. These results encourage further exploration of engineered B cell vaccines as a strategy for durable elicitation of HIV bnAbs to protect against infection and as a contributor to a functional cure.

immunology↗